Indian Drug Firms
-
Maiden Pharmaceuticals responsible for the deaths of 66 children, says Gambia Parliamentary panel
The select committee recommended that the Indian medicine manufacturer should be blacklisted and its products be banned in West African nation.
Scroll Staff
-
Maiden Pharma seeks to reopen factory after drug regulator says no contaminants in cough syrups
On Tuesday, the DCGI said that the WHO drew a premature link between the deaths of 66 children in The Gambia and the cough syrups made by Haryana-based company.
Scroll Staff
-
WHO drew premature link between deaths of children in Gambia and India-made cough syrups, says DCGI
Test reports have shown that the syrups were not contaminated with diethylene glycol or ethylene glycol, the drug regulator said.
Scroll Staff
Trending
-
A celebrity fitness instructor offers five rules of fitness for everyone
-
Why a celebrated Russian artist chose to become an Indian citizen
-
Months after controversy, IIT-Bombay sets aside space for those eating vegetarian food
-
Happy problem: As India peak in time for the World Cup, Dravid and Co have a problem of plenty
-
‘Kumari Srimathi’ review: An entertaining comedy laced with welcome tartness
-
Haryana stops production of cough syrups linked to deaths of 66 children in The Gambia
State health minister said that 12 flaws were found during an inspection of the medicines and their manufacturing process.
Scroll Staff
-
Gambia Police begin probe into deaths of children linked to India-made cough syrups
President Adama Barrow’s office said that the foreign ministry had been asked to communicate the government’s ‘most profound concern’ to the Indian embassy.
Scroll Staff
-
Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year
Meanwhile, the Food and Drug Administration in Haryana said it was preparing to test samples of the four syrups, which were made for export.
Tabassum Barnagarwala
Video
-
Watch: Hyderabad police personnel dance with crowd during Ganesh immersion procession
-
Watch: In Bengaluru, man gets pizza delivered to his car while it was stuck in traffic jam
-
‘You want to keep an alien as a pet?’: Comedian imagines the struggles parents might face in 2050
-
Watch: Man helps dugong calf stranded on Tamil Nadu beach back into the sea
-
Watch: Pakistan cricket team gets warm welcome in Hyderabad as they arrive in India for World Cup
-
Thalassemia patients complain of shortage of life-saving drug that removes excess iron from blood
However, Novartis, the sole manufacturer of the medicine, says that the stock is sufficient.
Priyanka Vora
-
Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
The new policy can keep Indian companies competitive and bring investment into the country.
Prashant Reddy